Valuation (9%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -32.49 | 20.37 |
| PEG Ratio (TTM) | -0.41 | 15.52 |
| P/S Ratio (TTM) | 6.99 | 2.36 |
| P/B Ratio (TTM) | 4.05 | 5.23 |
| P/FCF Ratio (TTM) | -6.14 | 23.74 |
| Price to 5YR AVG Earnings Ratio | N/A | 24.27 |
| Price to 5YR AVG FCF Ratio | N/A | 17.49 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.10% | 6.77% |
| ROE (TTM) | -12.78% | 21.61% |
| Net Profit Margin (TTM) | -21.38% | 10.07% |
| ROIC 5YR AVG | N/A | -32.74% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -26.74% | -624.95% | N/A |
| Revenue | 6.77% | 169.98% | N/A |
| Net Income | -27.94% | -33.42% | N/A |
| Cash Flow | -145.16% | -86.33% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.74 | 1.79 |
| Quick Ratio (TTM) | 1.50 | 1.35 |
| D/E Ratio (TTM) | 0.01 | 2.09 |
| Interest Coverage (TTM) | N/A | 10.94 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 3.93 |
| LTL to 5YR AVG FCF | N/A | 1.22 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.08% |